H.R. 2086 (108th): Office of National Drug Control Policy Reauthorization Act of 2003
May 14, 2003
108th Congress, 2003–2004
Died in a previous Congress
This bill was introduced in a previous session of Congress and was passed by the House on September 30, 2003 but was never passed by the Senate.
Representative for Indiana's 3rd congressional district
Read Text »
Last Updated: Oct 1, 2003
Length: 48 pages
About the bill
- Full Title
To reauthorize the Office of National Drug Control Policy.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Last Action: Mar 9, 2006
- What is a bill?
The “H.R.” in “H.R. 2086” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2086 — 108th Congress: Office of National Drug Control Policy Reauthorization Act of 2003. Retrieved from https://www.govtrack.us/congress/bills/108/hr2086
“H.R. 2086 — 108th Congress: Office of National Drug Control Policy Reauthorization Act of 2003.” www.GovTrack.us. 2003. May 5, 2015 <https://www.govtrack.us/congress/bills/108/hr2086>
|title=H.R. 2086 (108th)
|accessdate=May 5, 2015
|author=108th Congress (2003)
|date=May 14, 2003
|quote=Office of National Drug Control Policy Reauthorization Act of 2003